|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.944
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.877
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.780
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.690
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.682
|
|
|
|
inorganic anion transmembrane transport
|
GO:0098661 |
29 |
0.643
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.530
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.473
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.447
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.418
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.402
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.392
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.339
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.309
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.304
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.279
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.276
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.272
|
|
|
|
erythrocyte maturation
|
GO:0043249 |
6 |
0.269
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.268
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.266
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.245
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.229
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.225
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.223
|
|
|
|
response to oxygen radical
|
GO:0000305 |
16 |
0.212
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.211
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.206
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.203
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.201
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.199
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.197
|
|
|
|
thrombin receptor signaling pathway
|
GO:0070493 |
2 |
0.196
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.189
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.183
|
|
|
|
viral process
|
GO:0016032 |
41 |
0.176
|
|
|
|
regulation of chloride transport
|
GO:2001225 |
2 |
0.167
|
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.163
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.160
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.159
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.155
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.155
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.150
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.143
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.142
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.136
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.134
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.133
|
|
|
|
positive regulation of synaptic plasticity
|
GO:0031915 |
4 |
0.127
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.124
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.123
|
|
|
|
iron ion homeostasis
|
GO:0055072 |
36 |
0.121
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.121
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.117
|
|
|
|
regulation of erythrocyte differentiation
|
GO:0045646 |
23 |
0.116
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.113
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.112
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.111
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.110
|
|
|
|
cofactor biosynthetic process
|
GO:0051188 |
41 |
0.109
|
|
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.109
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.108
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.105
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.104
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.102
|
|
|
|
transition metal ion homeostasis
|
GO:0055076 |
54 |
0.101
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.100
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.100
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.100
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.096
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.094
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.093
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.093
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.092
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.091
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.090
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.090
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.089
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.089
|
|
|
|
dicarboxylic acid transport
|
GO:0006835 |
29 |
0.087
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.087
|
|
|
|
regulation of ph
|
GO:0006885 |
26 |
0.087
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.085
|
|
|
|
monovalent inorganic cation homeostasis
|
GO:0055067 |
33 |
0.085
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.085
|
|
|
|
translational initiation
|
GO:0006413 |
24 |
0.084
|
|
|
|
negative regulation of oxidative phosphorylation uncoupler activity
|
GO:2000276 |
2 |
0.082
|
|
|
|
positive regulation of cellular ph reduction
|
GO:0032849 |
2 |
0.081
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.081
|
|
|
|
killing by host of symbiont cells
|
GO:0051873 |
11 |
0.079
|
|
|
|
hemangioblast cell differentiation
|
GO:0060217 |
1 |
0.079
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.075
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.075
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.074
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.074
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.074
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.072
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.072
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.071
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.071
|
|
|
|
inorganic anion transport
|
GO:0015698 |
43 |
0.070
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.070
|
|
|
|
regulation of translational initiation in response to stress
|
GO:0043558 |
5 |
0.070
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.069
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.069
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.068
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.068
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.067
|
|
|
|
endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:0003199 |
4 |
0.067
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.067
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.067
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.067
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.067
|
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.066
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.066
|
|
|
|
ammonium transmembrane transport
|
GO:0072488 |
2 |
0.066
|
|
|
|
urea transport
|
GO:0015840 |
4 |
0.066
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.065
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.064
|
|
|
|
positive regulation of inner ear receptor cell differentiation
|
GO:2000982 |
1 |
0.064
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.063
|
|
|
|
methionine transport
|
GO:0015821 |
1 |
0.062
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.061
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.061
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.061
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.060
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.060
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.060
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.059
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.059
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.058
|
|
|
|
positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:2000764 |
1 |
0.058
|
|
|
|
cellular magnesium ion homeostasis
|
GO:0010961 |
3 |
0.058
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.057
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.057
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.057
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.056
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.056
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.056
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.055
|
|
|
|
chloride transport
|
GO:0006821 |
32 |
0.055
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.054
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.054
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
52 |
0.054
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process
|
GO:2000763 |
1 |
0.053
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.052
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.052
|
|
|
|
regulation of vascular smooth muscle contraction
|
GO:0003056 |
1 |
0.052
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.052
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.052
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.051
|
|
|
|
jak stat cascade
|
GO:0007259 |
42 |
0.051
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.051
|
|
|
|
positive regulation of mitochondrial calcium ion concentration
|
GO:0051561 |
3 |
0.050
|
|
|
|
alanine transport
|
GO:0032328 |
4 |
0.050
|
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.050
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.050
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.049
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.049
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.049
|
|
|
|
acyl coa biosynthetic process
|
GO:0071616 |
7 |
0.049
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.049
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.048
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.048
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.048
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.048
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.048
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.048
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.047
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.047
|
|
|
|
asparagine transport
|
GO:0006867 |
1 |
0.046
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.046
|
|
|
|
transepithelial chloride transport
|
GO:0030321 |
4 |
0.046
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.046
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.046
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.045
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.045
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.045
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.045
|
|
|
|
regulation of angiotensin levels in blood
|
GO:0002002 |
4 |
0.045
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.044
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.044
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.044
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.044
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.043
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.043
|
|
|
|
embryonic heart tube formation
|
GO:0003144 |
1 |
0.043
|
|
|
|
modification of morphology or physiology of other organism involved in symbiotic interaction
|
GO:0051817 |
16 |
0.042
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.042
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.042
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.042
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.042
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.042
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.041
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.041
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.041
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.041
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.040
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.040
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.040
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.040
|
|
|
|
regulation of retina development in camera type eye
|
GO:1902866 |
3 |
0.040
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.040
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.039
|
|
|
|
negative regulation of chromatin modification
|
GO:1903309 |
19 |
0.039
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.039
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.039
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.038
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.038
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.038
|
|
|
|
semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:0071527 |
1 |
0.038
|
|
|
|
regulation of oxidative phosphorylation uncoupler activity
|
GO:2000275 |
3 |
0.038
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.038
|
|
|
|
neural retina development
|
GO:0003407 |
41 |
0.038
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.037
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.037
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.037
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.037
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.037
|
|
|
|
negative regulation of glial cell derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation
|
GO:2000734 |
1 |
0.037
|
|
|
|
regulation of intestinal epithelial structure maintenance
|
GO:0060730 |
1 |
0.037
|
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.037
|
|
|
|
negative regulation of synapse maturation
|
GO:2000297 |
2 |
0.037
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.037
|
|
|
|
positive regulation of hematopoietic stem cell migration
|
GO:2000473 |
1 |
0.036
|
|
|
|
toxin transport
|
GO:1901998 |
38 |
0.036
|
|
|
|
l histidine transmembrane transport
|
GO:0089709 |
2 |
0.036
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.036
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.036
|
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.036
|
|
|
|
cell proliferation involved in heart valve development
|
GO:2000793 |
2 |
0.036
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.036
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.035
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.035
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.035
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.035
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
50 |
0.035
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.035
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.035
|
|
|
|
t helper 17 cell chemotaxis
|
GO:0035705 |
1 |
0.035
|
|
|
|
interleukin 6 production
|
GO:0032635 |
58 |
0.035
|
|
|
|
embryonic hemopoiesis
|
GO:0035162 |
23 |
0.035
|
|
|
|
regulation of hemostasis
|
GO:1900046 |
28 |
0.035
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.034
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.034
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.034
|
|
|
|
regulation of engulfment of apoptotic cell
|
GO:1901074 |
2 |
0.034
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.034
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.034
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.034
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.034
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.034
|
|
|
|
aspartate transport
|
GO:0015810 |
2 |
0.034
|
|
|
|
catecholamine uptake
|
GO:0090493 |
4 |
0.034
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.033
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.033
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.033
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.033
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.033
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.033
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.033
|
|
|
|
modification of morphology or physiology of other organism
|
GO:0035821 |
18 |
0.033
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.033
|
|
|
|
positive regulation of myeloid leukocyte differentiation
|
GO:0002763 |
26 |
0.033
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.033
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.033
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.033
|
|
|
|
regulation of auditory receptor cell differentiation
|
GO:0045607 |
4 |
0.033
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.033
|
|
|
|
fourth ventricle development
|
GO:0021592 |
2 |
0.033
|
|
|
|
regulation of gamma aminobutyric acid secretion
|
GO:0014052 |
2 |
0.033
|
|
|
|
regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000800 |
1 |
0.032
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.032
|
|
|
|
inner ear receptor cell differentiation
|
GO:0060113 |
61 |
0.032
|
|
|
|
regulation of growth of symbiont in host
|
GO:0044126 |
19 |
0.032
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.032
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.032
|
|
|
|
phospholipid transfer to membrane
|
GO:0006649 |
2 |
0.032
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.031
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.031
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.031
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.031
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.031
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.031
|
|
|
|
negative regulation of chromosome organization
|
GO:2001251 |
30 |
0.031
|
|
|
|
superoxide metabolic process
|
GO:0006801 |
27 |
0.030
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.030
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.030
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.030
|
|
|
|
transdifferentiation
|
GO:0060290 |
1 |
0.030
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.030
|
|
|
|
response to superoxide
|
GO:0000303 |
16 |
0.030
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.030
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.030
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.030
|
|
|
|
sclerotome development
|
GO:0061056 |
4 |
0.030
|
|
|
|
regulation of hematopoietic stem cell migration
|
GO:2000471 |
1 |
0.030
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.030
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.030
|
|
|
|
cellular response to interleukin 15
|
GO:0071350 |
2 |
0.029
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.029
|
|
|
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000802 |
1 |
0.029
|
|
|
|
sensory perception of light stimulus
|
GO:0050953 |
54 |
0.029
|
|
|
|
positive regulation of lymphocyte differentiation
|
GO:0045621 |
61 |
0.029
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.029
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.029
|
|
|
|
positive regulation of t cell receptor signaling pathway
|
GO:0050862 |
4 |
0.029
|
|
|
|
respiratory gaseous exchange
|
GO:0007585 |
43 |
0.029
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.029
|
|
|
|
cellular response to superoxide
|
GO:0071451 |
14 |
0.029
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.029
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.028
|
|
|
|
negative regulation of interleukin 5 production
|
GO:0032714 |
4 |
0.028
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.028
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.028
|
|
|
|
interaction with symbiont
|
GO:0051702 |
14 |
0.027
|
|
|
|
negative regulation of growth of symbiont involved in interaction with host
|
GO:0044146 |
19 |
0.027
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.027
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.027
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.027
|
|
|
|
lipoxin a4 biosynthetic process
|
GO:2001303 |
1 |
0.027
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.027
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.027
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.027
|
|
|
|
labyrinthine layer blood vessel development
|
GO:0060716 |
21 |
0.027
|
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
55 |
0.027
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.027
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
51 |
0.027
|
|
|
|
regulation of systemic arterial blood pressure by carotid body chemoreceptor signaling
|
GO:0003027 |
1 |
0.027
|
|
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
43 |
0.027
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
50 |
0.027
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.027
|
|
|
|
positive regulation of ureteric bud formation
|
GO:0072107 |
3 |
0.027
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.027
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.027
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.026
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.026
|
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.026
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.026
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.026
|
|
|
|
visual perception
|
GO:0007601 |
52 |
0.026
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.026
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.026
|
|
|
|
cellular transition metal ion homeostasis
|
GO:0046916 |
32 |
0.026
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.026
|
|
|
|
amino acid transmembrane transport
|
GO:0003333 |
37 |
0.026
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.026
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.026
|
|
|
|
neural nucleus development
|
GO:0048857 |
22 |
0.025
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.025
|
|
|
|
movement in environment of other organism involved in symbiotic interaction
|
GO:0052192 |
15 |
0.025
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.025
|
|
|
|
activation of innate immune response
|
GO:0002218 |
56 |
0.025
|
|
|
|
hydrogen peroxide catabolic process
|
GO:0042744 |
5 |
0.025
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.025
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.025
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.025
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.025
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.025
|
|
|
|
catecholamine metabolic process
|
GO:0006584 |
30 |
0.025
|
|
|
|
regulation of angiotensin metabolic process
|
GO:0060177 |
4 |
0.025
|
|
|
|
branched chain amino acid transport
|
GO:0015803 |
2 |
0.025
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.025
|
|
|
|
cardiac right ventricle formation
|
GO:0003219 |
3 |
0.025
|
|
|
|
cellular response to follicle stimulating hormone stimulus
|
GO:0071372 |
1 |
0.025
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.024
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.024
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.024
|
|
|
|
organ regeneration
|
GO:0031100 |
2 |
0.024
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.024
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.024
|
|
|
|
regulation of mast cell differentiation
|
GO:0060375 |
3 |
0.024
|
|
|
|
establishment of vesicle localization
|
GO:0051650 |
81 |
0.024
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.024
|
|
|
|
eosinophil mediated immunity
|
GO:0002447 |
1 |
0.024
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.024
|
|
|
|
regulation of protein acetylation
|
GO:1901983 |
22 |
0.024
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.024
|
|
|
|
positive regulation of t cell extravasation
|
GO:2000409 |
2 |
0.024
|
|
|
|
eosinophil activation
|
GO:0043307 |
1 |
0.024
|
|
|
|
removal of superoxide radicals
|
GO:0019430 |
12 |
0.024
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.024
|
|
|
|
wnt signaling pathway involved in kidney development
|
GO:0061289 |
2 |
0.024
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.024
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.023
|
|
|
|
dopamine uptake involved in synaptic transmission
|
GO:0051583 |
4 |
0.023
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.023
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.023
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.023
|
|
|
|
positive regulation of interferon gamma production
|
GO:0032729 |
39 |
0.023
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.023
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.023
|
|
|
|
catecholamine biosynthetic process
|
GO:0042423 |
11 |
0.023
|
|
|
|
regulation of peptidyl lysine acetylation
|
GO:2000756 |
22 |
0.023
|
|
|
|
ceramide metabolic process
|
GO:0006672 |
31 |
0.023
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.023
|
|
|
|
regulation of excitatory postsynaptic membrane potential
|
GO:0060079 |
41 |
0.023
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.023
|
|
|
|
regulation of anion transport
|
GO:0044070 |
27 |
0.023
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.023
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.023
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.023
|
|
|
|
regulation of cellular ph
|
GO:0030641 |
12 |
0.023
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.023
|
|
|
|
phosphatidylethanolamine metabolic process
|
GO:0046337 |
2 |
0.023
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.022
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.022
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.022
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.022
|
|
|
|
regulation of interleukin 1 alpha production
|
GO:0032650 |
4 |
0.022
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.022
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.022
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.022
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.022
|
|
|
|
receptor internalization
|
GO:0031623 |
16 |
0.022
|
|
|
|
myeloid leukocyte mediated immunity
|
GO:0002444 |
42 |
0.022
|
|
|
|
regulation of histone methylation
|
GO:0031060 |
30 |
0.022
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.022
|
|
|
|
monocyte extravasation
|
GO:0035696 |
2 |
0.022
|
|
|
|
regulation of tumor necrosis factor production
|
GO:0032680 |
49 |
0.022
|
|
|
|
viral life cycle
|
GO:0019058 |
36 |
0.022
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.022
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.022
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.022
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.022
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.022
|
|
|
|
regulation of histone h3 k4 methylation
|
GO:0051569 |
12 |
0.022
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.022
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.021
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.021
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.021
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.021
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.021
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.021
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.021
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.021
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.021
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.021
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.021
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.021
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.021
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.021
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.021
|
|
|
|
coenzyme biosynthetic process
|
GO:0009108 |
23 |
0.021
|
|
|
|
l amino acid transport
|
GO:0015807 |
32 |
0.021
|
|
|
|
regulation of macrophage activation
|
GO:0043030 |
17 |
0.021
|
|
|
|
mast cell proliferation
|
GO:0070662 |
4 |
0.021
|
|
|
|
regulation of chemokine production
|
GO:0032642 |
30 |
0.021
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.021
|
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
26 |
0.021
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.021
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.021
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.020
|
|
|
|
regulation of cellular ph reduction
|
GO:0032847 |
2 |
0.020
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.020
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.020
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.020
|
|
|
|
regulation of t cell mediated cytotoxicity
|
GO:0001914 |
18 |
0.020
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.020
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.020
|
|
|
|
antibiotic transport
|
GO:0042891 |
1 |
0.020
|
|
|
|
tendon formation
|
GO:0035992 |
4 |
0.020
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.020
|
|
|
|
positive regulation of viral entry into host cell
|
GO:0046598 |
3 |
0.020
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.020
|
|
|
|
regulation of immune complex clearance by monocytes and macrophages
|
GO:0090264 |
2 |
0.020
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.020
|
|
|
|
auditory receptor cell fate determination
|
GO:0042668 |
3 |
0.020
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.020
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.020
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.020
|
|
|
|
tetrapyrrole metabolic process
|
GO:0033013 |
22 |
0.020
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.020
|
|
|
|
eosinophil differentiation
|
GO:0030222 |
1 |
0.020
|
|
|
|
eosinophil activation involved in immune response
|
GO:0002278 |
1 |
0.020
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.020
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.020
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.020
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.020
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.020
|
|
|
|
regulation of inward rectifier potassium channel activity
|
GO:1901979 |
1 |
0.020
|
|
|
|
tetrapyrrole biosynthetic process
|
GO:0033014 |
16 |
0.020
|
|
|
|
multicellular organismal metabolic process
|
GO:0044236 |
28 |
0.020
|
|